Prolinx, Inc. Awarded Frost & Sullivan 2002 Technology Innovation Award for Proteomics Platform Technology.Business Editors, Health/Medical Writers BIOWIRE2K BOTHELL, Wash.--(BW HealthWire)--May 17, 2002 Prolinx(R), Inc. announced today that the company has been selected to receive the 2002 Market Engineering Technology Innovation Award by Frost & Sullivan for its Versalinx(TM) Protein Microarray A protein microarray is a piece of glass on which different molecules of protein have been affixed at separate locations in an ordered manner thus forming a microscopic array. Technology. Frost & Sullivan, an international strategic market consulting and training firm founded in 1961, presents these awards to companies that demonstrate the diligence, perseverance, and dedication required to develop a successful business plan and excel in the increasingly competitive global marketplace. Protein arrays, also known as protein biochips, are a collection of discrete protein or peptide spots on a solid surface, each of which represents an individual assay. The use of protein arrays is a rapid and cost effective method for screening a large number of samples for proteomics and drug discovery research applications and represents an emerging growth market. Protein arrays, analogous to DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. arrays used widely in genomics applications, represent a technological challenge for researchers due to the fact that proteins and peptides are fragile and vary widely in structure and function. Versalinx Protein Microarray Technology is a universal, open-platform protein or peptide array system based on the Prolinx Versalinx synthetic small molecule, affinity chemistry. Versalinx technology provides the robust and highly stable surface chemistry that overcomes the challenges presented by protein arrays, enabling development of sensitive protein biochips. Advantages include: individual array elements may be optimized to maximize performance of each individual protein or peptide yielding high signal-to-noise ratios The ratio of the power or volume (amplitude) of a signal to the amount of unwanted interference (the noise) that has mixed in with it. Measured in decibels, signal-to-noise ratio (SNR or S/N) measures the clarity of the signal in a circuit or a wired or wireless transmission channel. , uniform spot morphology and signal intensities with fewer assay steps. The technology is fully compatible with existing automated techniques and systems, resulting in increased efficiency and reduced potential for human error. Prolinx released the Versalinx Protein Microarray product line in late 2001. The Frost & Sullivan Engineering Award for Technology Innovation was awarded to Prolinx, Inc. for the development of an enabling technology that addresses a significant challenge in the protein array marketplace. This award recognizes the ability of the company to successfully develop and introduce new technology, formulate a well-designed product family, and make significant product performance contributions to the industry. The award resulted from an analyst team research project on emerging and existing technologies and R&D developments. This project involved interviews with major market participants and extensive secondary research. Also considered were elements such as product launches, customer acceptance, penetration rates and time to market. "The protein array market has been restrained due to technical challenges inherent in maintaining full function following protein immobilization Immobilization Definition Immobilization refers to the process of holding a joint or bone in place with a splint, cast, or brace. This is done to prevent an injured area from moving while it heals. ," stated Eric Gay, industry analyst "The Versalinx(TM) Protein Microarray technology is a powerful tool in not only this respect, but also in enabling the immobilization and instantaneous optimization of proteins with distinct chemistries on the same surface. We anticipate rapid market penetration Noun 1. market penetration - the extent to which a product is recognized and bought by customers in a particular market penetration - the act of entering into or through something; "the penetration of upper management by women" for this technology in a market where the ability to define content is paramount." "Receiving the Frost & Sullivan Award A Sullivan Award may refer to:
James Thomas Mahoney (born on May 26, 1934 in Englewood, New Jersey) is a former Major League Baseball shortstop. He was signed by the Philadelphia Phillies before the 1953 season and played for the Boston Red Sox (1959), the , President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "The extraordinary focus, high standard of technical excellence, creativity and dedication of the entire Prolinx team allowed us to bring this enabling technology to market very quickly. The team continues to innovate and will continue to introduce new products focused on the emerging proteomics market." Prolinx, founded in 1995, is a privately held biotechnology company located north of Seattle, Washington  This page is protected from moves until disputes have been resolved on the .The reason for its protection is listed on the protection policy page. , USA. The company develops, manufactures, and markets chemistry based tools, applications, and systems that advance developments in bioresearch bi·o·re·search n. Research in the biological sciences. , biotechnology and drug discovery. The company has commercialized a number of proprietary technologies including: Versalinx(TM) Chemical Affinity In physical chemistry, chemical affinity, historically, refers to the "force" that causes chemical reactions.[1] A broad definition, used generally throughout history, is that chemical affinity is that whereby substances enter into or resist decomposition. Tools, a synthetic chemical affinity technology targeted at the proteomics and genomics markets; Versalinx Protein Microarray Technology, a novel open platform array system specifically designed to enable developments in the emerging protein and peptide chip market; and RapXtract Superparamagnetic Separation Technology for the purification of fluorescent labeling reactions used in sequencing and microarray applications. The company is also developing instrumentation for label-free molecular interaction analysis based upon advances in surface plasmon resonance The excitation of surface plasmons by light is denoted as a surface plasmon resonance (SPR) for planar surfaces or localized surface plasmon resonance (LSPR) for nanometer-sized metallic structures. technology. The first instrument, the Octave(TM) Molecular Interaction Analysis System, will be released in 2002. Information about Prolinx is available at www.prolinx.com or by phoning 425/487-3401. Prolinx is a registered trademark, and Octave, RapXtract and Versalinx are trademarks, of Prolinx, Inc. Search terms: Proteomics, protein array, protein microarray, protein biochip biochip Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of , protein, peptide |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion